Law firm Stephenson Harwood LLP has advised long-standing diagnostics client Novacyt S.A. in relation to its recommended takeover of Yourgene Health plc, an international integrated technologies and services business which enables the delivery of genomic medicine.
Both Novacyt and Yourgene are listed on AIM and Novacyt is also listed on Euronext Growth Paris. The transaction was governed by the Takeover Code and effected by a court-sanctioned scheme of arrangement under Part 26 of the Companies Act. The takeover aligns with Novacyt's post Covid-19 strategy, which focuses on portfolio development and geographic expansion.
The Stephenson Harwood team was led by corporate partner Tom Page. Further support was provided by, amongst others, managing associate Victoria Silver and associate Tom O'Connor on the corporate aspects; partner Alexandra Pygall and managing associate Anne Stoffels in relation to IP; partner Dan Holland and associate Kate Ackland in relation to commercial contracts; partner Marta Garcia, managing associate Bryony Roy and associate Will Spens in relation to competition law; partner Nicolas Stretch and associate Desiree De Lima on incentives; partner Dan Margolis and managing associate David Harris on the finance aspects; members of the London and Paris litigation teams; the London employment team; and the Singapore corporate team.